Celltrion
068270.KS
#823
Rank
C$33.47 B
Marketcap
$153.74
Share price
0.32%
Change (1 day)
-14.35%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.04

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.15. In 2022 the company made an earnings per share (EPS) of $4.04 a decrease over its 2021 EPS that were of $4.80.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.040.01%
2022$4.04-15.84%
2021$4.8012.77%
2020$4.2570.79%
2019$2.4915.63%
2018$2.15-33.13%
2017$3.22141.17%
2016$1.348.28%
2015$1.2311.28%
2014$1.1116.37%
2013$0.95-67.42%
2012$2.9284.22%
2011$1.5962.13%
2010$0.9880.61%
2009$0.54-559.63%
2008-$0.12-123.16%
2007$0.51